Colorectal Cancer: Susanna's Patient Story

Patient Info: Susanna Zier, Female, 60s

As of spring 2013, Susanna was receiving chemotherapy after urgent colorectal cancer surgery, generally feeling well despite fatigue, taste changes, skin/nosebleed problems, finger symptoms, and port-related issues.

Krankheitserfahrungen.deRead more →

Stage IV Colorectal Cancer: Uwe's Patient Story

Patient Info: Uwe Dierks, Male, 60s | Stage IV

Biomarkers: Not reported; family history of colorectal cancer in mother

Metastatic Site: Lung

As of July 2023, Uwe was living after rectal cancer, lung metastasis treatment, permanent stoma placement, multiple complications, and ongoing pancreatic-insufficiency and quality-of-life challenges.

Krankheitserfahrungen.deRead more →

Colorectal Cancer: Jan's Survivor Story

Patient Info: Jan Holgersson, Male, 50s | Stage Metastatic/Advanced

As of winter 2012/2013, Jan had completed radiation, surgery, and multiple chemotherapy cycles for rectal/colorectal cancer, adapted to a permanent colostomy, and reported improved life satisfaction despite work limitations.

Krankheitserfahrungen.deRead more →

Colorectal Cancer: Lisa's Survivor Story

Patient Info: Lisa Roth, Female, 50s

Biomarkers: Lynch syndrome / HNPCC

By winter 2012/2013, Lisa was free of metastases and recurrence after surgery for Lynch syndrome-associated colorectal cancer, and she had become active in hereditary colorectal cancer self-help.

Krankheitserfahrungen.deRead more →

Colorectal Cancer: Klaus's Survivor Story

Patient Info: Klaus Wippich, Male, 60s

By summer 2012, Klaus had lived for decades after rectal cancer surgery, adapted well to a permanent colostomy, returned to work after about 1 year, and later became active in ILCO self-help.

Krankheitserfahrungen.deRead more →

Stage IV Lung Cancer: Hakim's Patient Story

Patient Info: Hakim Rusli, Male | Stage IV

Metastatic Site: Brain

Stage IV lung cancer with brain metastasis became controlled after care at Modern Cancer Hospital Guangzhou; progression slowed and symptoms/supportive issues were managed, but no remission or NED status is reported.

Stage IV Lung Cancer: Mila's Patient Story

Patient Info: Mila Gardon, Female, 50s | Stage IV

Metastatic Site: Neck lymph nodes; skull; iliac bone

Stage IV lung cancer with spread to neck lymph nodes, skull, and iliac bone responded after cryotherapy and interventional therapy; lung tumors disappeared and tumor marker normalized, but the source does not state full remission or NED.

Stage IV ALK Lung Cancer: Jay's Survivor Story

Patient Info: Jay Petri, Male | Stage IV

Biomarkers: ALK mutation / ALK-rearranged lung cancer

Metastatic Site: Not reported

Stage IV ALK-positive lung cancer treated through clinical trials at Mass General; he reported being cancer-free for nearly 1.5 years after going through 3 trials.

Massachusetts General HospitalRead more →

Stage I Breast Cancer: Dianne's Survivor Story

Patient Info: Dianne Austin, Female, 40s | Stage I

Disease-free after treatment for early Stage I breast cancer, with chemotherapy and radiation completed and ongoing survivorship focused on resilience, hair loss recovery, and advocacy for better wig access for women of color.

Massachusetts General HospitalRead more →

Stage III ALK Non-Small Cell Lung Cancer: Michelle's Patient Story

Patient Info: Michelle Bos-Lun, Female | Stage III

Biomarkers: ALK-positive

Stage IIIB ALK-positive lung cancer responding to Lorbrena/lorlatinib, with cough improvement within days and first scan showing nearly 50% tumor reduction.

GO2 FoundationRead more →

Stage II Colorectal Cancer: Deondre's Survivor Story

Patient Info: Deondre Williams, Male, Under 40 | Stage II

Stage II colon cancer survivor who is described as cancer-free and now works as a life coach, speaker, and colorectal cancer awareness advocate.

Colorectal Cancer AllianceRead more →

Stage III Colorectal Cancer: Gabriel's Survivor Story

Patient Info: Gabriel Leblanc, Male, Under 40 | Stage III

Stage III colon cancer survivor who avoided an ostomy after total colectomy, completed chemotherapy, returned to full-time work, and is described in the source as moving from Stage III to NED.

Colorectal Cancer AllianceRead more →

Breast Cancer: Roger's Patient Story

Patient Info: Roger, Male

Managing male breast cancer care on a lower dose of tamoxifen after severe side effects, while using support services and advocating for male breast cancer awareness.

Breast Cancer: Susan's Survivor Story

Patient Info: Susan, Female, 60s

Susan had been deemed cancer-free for 10 years after breast cancer treatment, while continuing to manage chronic lymphedema through MSK support services.

Memorial Sloan KetteringRead more →

Severe blood-clotting disorder, liver injury, and reversible kidney injury during treatment for Stage IV lung cancer

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: PD-L1 about 1%; KRAS mutation

Metastatic Site: bone (right 4th and 5th ribs)

Restaging before cycle 4 showed a partial response. Cancer treatment was then interrupted as severe acquired iTTP, cholestatic liver injury, and reversible acute kidney injury required intensive management.

PubMed CentralRead more →

Lung cancer first discovered after a small-bowel blockage

Patient Info: Anonymized, Male, 50s | Stage IV

Metastatic Site: jejunum|brain|bone

The cancer progressed to the brain and spine despite chemotherapy, and he was admitted to palliative care.

PubMed CentralRead more →

Stage IIIB lung cancer: heart inflammation from durvalumab immunotherapy, mistaken at first for tumor spreading to the heart

Patient Info: Anonymized, Female, 70+ | Stage III

Biomarkers: No actionable driver mutations identified; PD-L1 tumor proportion score <1%

She recovered cardiac function after treatment for durvalumab-associated myocarditis and remained without lung-cancer relapse or cardiac decline for more than 4 years, with no additional anticancer therapy.

PubMed CentralRead more →

Stage IV rectal cancer with liver metastases and a rare tumor subtype

Patient Info: Anonymized, Male, 50s | Stage IV

Biomarkers: HER2 amplification; KRAS/NRAS wild type; microsatellite stable

Metastatic Site: liver

He declined systemic treatment, entered home hospice, and died in August 2025 with Stage IV rectal cancer.

PubMed CentralRead more →

RET-positive Stage IV lung cancer: targeted therapy stopped after severe side effects

Patient Info: Anonymized, Female, 70+ | Stage IV

Biomarkers: RET fusion

Metastatic Site: brain|bone

Selpercatinib produced early shrinkage of the lung tumor and brain metastases, but it was permanently discontinued because of recurrent severe side effects. She was transferred for supportive care.

PubMed CentralRead more →

Rare ovarian cancer diagnosed during pregnancy after an initial misdiagnosis

Patient Info: Anonymized, Female, Under 40 | Stage IV

Biomarkers: SMARCA4 and TP53 alterations

Metastatic Site: liver|spleen|bone

After a complete response in July 2024, the cancer recurred widely within about 6 months. She died from progressive disease in January 2025.

PubMed CentralRead more →

Hormone receptor-positive, HER2-positive breast cancer treatment interrupted by vaginal cuff dehiscence and bowel evisceration

Patient Info: Anonymized, Female, 70+ | Stage III

Biomarkers: Hormone receptor-positive; HER2-positive

At 21 months after emergency repair, she was symptom-free with POP-Q stage 0; letrozole continued and T-DM1 was resumed 7 weeks after discharge, but long-term cancer response was not detailed.

PubMed CentralRead more →

Stage IV EGFR-mutated lung adenocarcinoma: high-dose furmonertinib after CNS progression

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Initial EGFR L858R mutation. Later blood testing showed EGFR p.S553Y variation; CEA rose and fell with treatment.

Metastatic Site: brain/meninges; bilateral pleura/lungs; mediastinal…

As of June-September 2024, the left lung lesion was stable to slightly smaller on escalated furmonertinib, but brain/CNS lesions had progressed and required dose escalation to 240 mg/day; later imaging was declined.

PubMed CentralRead more →

Stage I Invasive Ductal Carcinoma: Rachel's Patient Story

Patient Info: Rachel, Female | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

As of June 2026, Rachel had completed double mastectomy and chemotherapy for Stage IB breast cancer and remained on planned 10-year tamoxifen therapy, with ongoing joint/muscle pain, weight gain, and survivorship effects.

The Patient StoryRead more →

Recurrent squamous lung cancer with tumor emboli, acute limb ischemia, brain metastases, and death

Patient Info: Anonymized, Male, 60s | Stage Metastatic/Advanced

Biomarkers: p40-positive; TTF-1-negative; PD-L1 not expressed / no PD-L1 reported in raw case

Metastatic Site: brain/cerebral metastases; tumor emboli in upper and…

The patient developed recurrent acute limb ischemia from tumor emboli, then new cerebral metastases, and died from advanced disease 7 months after the bilateral lower-limb ischemia presentation.

PubMed CentralRead more →